Prediction Case File
YouTubeEvaluation Complete

Solana (SOL) price prediction reaches $400 by year's end, fueled by chart analysis. Upcoming ETFs could impact the forecast, but optimism prevails based on technical indicators.

1 extracted signal · 1 resolved · 0 still active

Trade Confident profile imageTrade Confident21 Oct 2025, 23:18 UTC
Video preview for Solana (SOL) price prediction reaches $400 by year's end, fueled by chart analysis. Upcoming ETFs could impact the forecast, but optimism prevails based on technical indicators.
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analyst provides a technical analysis for SOL. The aggressive price target for Solana by the end of the year is $400. This target aligns with a 1.618 extension. The ETFs are coming out. The analyst is looking at exits with data.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Trade Confident

Tracked signals
565
Historical success
33.4%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.